Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components
1973 · Journal of Lipid Research · 77 citations
https://doi.org/10.1016/s0022-2275(20)36894-2
M
Mark Avigan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
5.3K
Citations
36
h-index
70
i10-index
Mark Avigan is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Drug-Induced Hepatotoxicity and Protection & Liver Disease Diagnosis and Treatment & Pharmacogenetics and Drug Metabolism. The author has an h-index of 36, co-authored 88 publications.
Papers by this author
worksBest practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development
2020 · Journal of Autoimmunity · 70 citations
https://doi.org/10.1016/j.jaut.2020.102514
Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials
2014 · Drug Safety · 41 citations
https://doi.org/10.1007/s40264-014-0183-6
The Clinical Liver Safety Assessment Best Practices Workshop: Rationale, Goals, Accomplishments and the Future
2014 · Drug Safety · 28 citations
https://doi.org/10.1007/s40264-014-0181-8
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy
2024 · Drug Safety · 14 citations
https://doi.org/10.1007/s40264-024-01399-4
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations
2024 · Digestive Diseases and Sciences · 5 citations
https://doi.org/10.1007/s10620-023-08251-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat